What is Semaglutide?
Semaglutide, also known as Ozempic, is the latest arrival in a successful weight loss aid, which does not require any special diet or sacrifice to see results.Semaglutide is a glucagon-like peptide receptor antogonist which basically improves glycemic control in the pancreas. Semaglutide will delay gastric emptying by reducing glucogon secretion which reduces appetite, lowers sugar cravings and improves overall ability to control eating habits. Semaglutide is an FDA-approved injectable glucagon-like peptide-1 (GLP-1) agonist that is administered once weekly to help you with long-term weight management.
How does Semaglutide help me?
GLP-1 is an incretin hormone that plays a role in your appetite and digestion. Incretins — hormones released by your small intestine — are sent out by your body after you’ve eaten a meal to help lower your blood sugar by triggering insulin and blocking other sources of sugar. It also slows down how quickly food leaves your stomach (called gastric emptying). The result of these actions causes you to feel full — lowering your appetite and causing you to lose weight.
Who is Semaglutide for?
Semaglutide offers adults experiencing obesity or overweight a beneficial FDA-approved treatment option for chronic weight management. This once-per-week injection is specifically designed for adults who experience weight-related conditions, such as high blood pressure, type 2 diabetes, or high cholesterol. The injection often benefits patients who struggle to control their food intake. The treatment may be an option for adults who are living with obesity (BMI ≥30) or excess weight (BMI ≥27).
How is Semaglutide Administered?
You’ll give yourself the injection once a week, on the same day each week. It can be given at any time of day, and you can take it with or without food. Semaglutide is injected just under the skin (subcutaneously) in your abdomen.
Are there any side effects?
Semaglutide is an FDA-approved medication and is clinically-tested, stimulant-free, and non-habit forming. In a recent clinical trial, less than 5% of people discontinued GLP-1 medications because of side effects. Nausea is the most common, and this has been shown to typically resolve over the first weeks of being on the medication.
